Slate Therapeutics Revenue

Biotechnology Research • • 1-10 Employees

Slate Therapeutics revenue & valuation

Annual revenue	$171,110
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$547,552
Total funding	No funding

Key Contact at Slate Therapeutics

Matan Soll

Chief Executive Officer

Company overview

Headquarters	XX
Website	slatetherapeutics.com
NAICS	541714
Employees	1-10

Slate Therapeutics Email Formats

Slate Therapeutics uses 1 email format. The most common is {first name} (e.g., john@slatetherapeutics.com), used 100% of the time.

Format	Example	Percentage
{first name}	john@slatetherapeutics.com	100%

About Slate Therapeutics

Slate Therapeutics: Pioneering Long-Acting Drug Delivery for CRS, Neurology & Obesity: At Slate Therapeutics, we are revolutionizing long-acting drug delivery with innovative sinus-to-brain and oral extended-release technologies. Our proprietary platform enables weeks-to-months of controlled drug release, transforming treatment for chronic rhinosinusitis (CRS), neurological disorders, and metabolic diseases—including obesity. Our Drug Delivery Platforms 🔹 Sinus Drug Delivery: Our proprietary formulation provides over 45 days of sustained release when placed in the sinus, offering a game-changing approach for CRS and direct-to-brain drug delivery via the olfactory pathway. 🔹 Long-Acting Oral Drug Delivery (Obesity & Metabolic Disease): Expanding beyond CRS, we are developing an extended-release oral platform designed to enhance drug efficacy, reduce dosing frequency, and improve patient adherence. Our initial focus is on obesity and metabolic syndromes, addressing the rapidly growing demand for next-generation weight loss treatments.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Employees by Department

Slate Therapeutics has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

Slate Therapeutics has never raised funding before.

Frequently asked questions

Slate Therapeutics is located in XX.

Slate Therapeutics generates an estimated annual revenue of $171,110. This revenue figure reflects the company's market position and business performance in its industry.

Slate Therapeutics has an estimated valuation of $547,552. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Slate Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at Slate Therapeutics

Matan Soll

Chief Executive Officer

4.8

40,000 users